n-acetyl-4-s-cysteaminylphenol has been researched along with levodopa in 1 studies
| Studies (n-acetyl-4-s-cysteaminylphenol) | Trials (n-acetyl-4-s-cysteaminylphenol) | Recent Studies (post-2010) (n-acetyl-4-s-cysteaminylphenol) | Studies (levodopa) | Trials (levodopa) | Recent Studies (post-2010) (levodopa) |
|---|---|---|---|---|---|
| 19 | 0 | 0 | 17,774 | 1,900 | 4,946 |
| Protein | Taxonomy | n-acetyl-4-s-cysteaminylphenol (IC50) | levodopa (IC50) |
|---|---|---|---|
| integrase, partial | Human immunodeficiency virus 1 | 0.5939 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 0.5939 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 2.88 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 3.729 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 2.146 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.258 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, S; Jimbow, K; Miura, T | 1 |
1 other study(ies) available for n-acetyl-4-s-cysteaminylphenol and levodopa
| Article | Year |
|---|---|
The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Topics: Animals; Antineoplastic Agents; Carbidopa; Cell Division; Cysteamine; Cysteine; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Kinetics; Levodopa; Melanoma, Experimental; Mice; Mice, Inbred Strains; Monophenol Monooxygenase; Neoplasm Transplantation; Phenols; Substrate Specificity | 1990 |